SLS BIO Co., Ltd (KOSDAQ:246250)

South Korea · Delayed Price · Currency is KRW

1,969.00

+85.00 (4.51%)

At close: Jun 9, 2025

SLS BIO Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2015
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '15 Dec 31, 2015
Revenue	2,889	3,984	8,371	9,023	10,752	6,214
Revenue Growth	-60.39%	-52.41%	-7.23%	-16.08%	73.02%	6.75%
Gross Profit	-2,571	-1,937	2,269	3,111	4,210	1,363
Operating Income	-5,060	-4,105	287.62	1,031	2,424	522.53
Net Income	-5,428	-4,904	335.63	1,434	2,826	204.47
Earnings Per Share	-361.14	-325.88	22.00	102.00	412.00	41.00
EPS Growth	-	-	-78.43%	-75.24%	904.88%	-44.59%

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2015
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '15 Dec 31, 2015
Cash & Investments	1,835	3,324	7,680	9,355	2,548	1,966
Total Debt	1,436	1,314	1,710	2,105	2,517	4,111
Net Cash (Debt)	399.16	2,010	5,970	7,250	30.98	-2,144
Net Cash Growth	-92.20%	-66.33%	-17.66%	23304.74%	-	-
Net Cash Per Share	26.56	133.60	391.34	515.69	4.52	-430.00

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2015
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '15 Dec 31, 2015
Operating Cash Flow	-3,701	-2,195	1,726	3,436	4,034	724.79
Capital Expenditures	-1,108	-1,514	-1,456	-1,274	-719.23	-627.13
Free Cash Flow	-4,809	-3,709	269.92	2,162	3,315	97.66
Free Cash Flow Growth	-	-	-87.51%	-34.79%	3294.14%	-88.45%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2015
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '15 Dec 31, 2015
Gross Margin	-88.99%	-48.63%	27.10%	34.48%	39.16%	21.93%
Operating Margin	-175.14%	-103.05%	3.44%	11.43%	22.54%	8.41%
Pretax Margin	-217.85%	-135.04%	4.23%	11.72%	20.69%	3.18%
Profit Margin	-187.86%	-123.09%	4.01%	15.89%	26.28%	3.29%
FCF Margin	-166.44%	-93.09%	3.22%	23.96%	30.83%	1.57%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2015
Period Ending	Oct '26 Oct 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '15 Dec 31, 2015
PE Ratio	-	-	78.33	24.57	12.02	-
P/FCF Ratio	-	-	97.39	16.30	10.25	-
PS Ratio	9.31	6.75	3.14	3.91	3.16	-